Cold medicine bills increased by 90% due to the coronavirus
By Lee, Tak-Sun | translator Kim, Jung-Ju
23.08.30 05:50:55
가나다라
0
Easing documentation for price increases for essential medicines due to supply and demand instability due to COVID-19, etc.
Guidelines for mediation and negotiation to be prepared in October… Briefing session scheduled for companies
▲Jeong Hae-min, head of the NHIS Pharmaceutical Management Department, is answering questions at the Professional Journalists
Due to the increase in confirmed cases of COVID-19 last year, cold medicine bills alone increased by 90% compared to the previous year. Based on the past five years, claims for COVID-19-related drugs were the highest in 2022. The NHIS conducted negotiations on linking usage and drug price reduction for 36 items related to COVID-19 and agreed on a reduction rate by applying a correction plan. The NHIS Pharmaceutical Management Office announced this at a meeting with the Professional Journalists Council on the 29th.According to NHIS, as a result of analyzing the billing amount for 2,637 cold medicine and antibiotic items last year, cold medicine billing amounted to 664.5 billion won and antibiotic billi
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)